AP

Amal Palaparambil Uday

Director Director DIN 07600212
DIN 07600212 First appointment Aug 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Aug 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Amal Palaparambil Uday

Data last updated:

Amal Palaparambil Uday has 10 years in corporate governance. Formerly with 1 company, such as Ar Diagnostics Health Care & Polyclinic Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 07600212
Primary Designation Director
First Appointment 26 Aug 2016
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Aug 20162016–Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ar Diagnostics Health Care & Polyclinic Private Limited
Premium access

Shareholding and investment profile for Amal Palaparambil Uday

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amal Palaparambil Uday

Amal Palaparambil Uday has 10 years in corporate governance. Formerly with 1 company, such as Ar Diagnostics Health Care & Polyclinic Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Amal Palaparambil Uday has expertise in Healthcare.

Amal Palaparambil Uday has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available